A detailed history of Perfromance Wealth Partners, LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Perfromance Wealth Partners, LLC holds 1,910 shares of ZTS stock, worth $337,993. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,910
Previous 1,358 40.65%
Holding current value
$337,993
Previous $235,000 58.72%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$172.58 - $196.48 $95,264 - $108,456
552 Added 40.65%
1,910 $373,000
Q2 2024

Jul 19, 2024

SELL
$145.54 - $178.83 $211,469 - $259,839
-1,453 Reduced 51.69%
1,358 $235,000
Q1 2024

Apr 30, 2024

SELL
$165.67 - $199.94 $5.44 Million - $6.57 Million
-32,844 Reduced 92.12%
2,811 $475,000
Q4 2023

Jan 22, 2024

SELL
$151.44 - $200.09 $3.59 Million - $4.75 Million
-23,723 Reduced 39.95%
35,655 $7.04 Million
Q3 2023

Oct 30, 2023

SELL
$167.14 - $192.77 $1.58 Million - $1.82 Million
-9,446 Reduced 13.72%
59,378 $10.3 Million
Q2 2023

Jul 13, 2023

SELL
$160.94 - $186.23 $1.13 Million - $1.31 Million
-7,028 Reduced 9.27%
68,824 $11.9 Million
Q1 2023

Apr 20, 2023

SELL
$145.48 - $175.02 $2.96 Million - $3.56 Million
-20,318 Reduced 21.13%
75,852 $12.6 Million
Q4 2022

Jan 19, 2023

SELL
$131.14 - $157.47 $1.57 Million - $1.89 Million
-11,990 Reduced 11.09%
96,170 $0
Q3 2022

Oct 17, 2022

SELL
$148.29 - $182.55 $584,410 - $719,429
-3,941 Reduced 3.52%
108,160 $16 Million
Q2 2022

Jul 15, 2022

SELL
$155.97 - $200.09 $967,793 - $1.24 Million
-6,205 Reduced 5.24%
112,101 $19.3 Million
Q1 2022

Apr 21, 2022

SELL
$181.39 - $234.03 $744,968 - $961,161
-4,107 Reduced 3.36%
118,306 $22.3 Million
Q4 2021

Feb 03, 2022

BUY
$193.69 - $247.03 $23.7 Million - $30.2 Million
122,413 New
122,413 $29.9 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Perfromance Wealth Partners, LLC Portfolio

Follow Perfromance Wealth Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perfromance Wealth Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perfromance Wealth Partners, LLC with notifications on news.